Skip to main content

InVitro International

corporate_fare Company Profile

InVitro International

IVRO·OTC·Life Sciences·CIK 0001341401

InVitro International develops test kits for non-animal testing applications in the United States and internationally. The company's product portfolio includes the Irritection Assay System, an in vitro test that predicts the ocular and dermal irritancy of chemicals, mixtures, and product formulations by observing changes in relevant macromolecules. Another key product is Corrositex, a non-animal test designed to determine skin corrosivity using a biomembrane and chemical detection systems. Beyond test kits, InVitro International offers customized technology services, specifically for the installation and testing processes of the Irritection Assay System. The company also provides independent testing laboratory services for irritancy and corrosivity testing requirements, alongside consultation and assistance services. InVitro International's products are primarily utilized across various industries, including cosmetics, personal care, household products, textiles, pharmaceuticals, chemicals, hazardous waste, and transportation. Incorporated in 1985, InVitro International is headquartered in Placentia, California.

InVitro International (OTC:IVRO) is a publicly traded company in the Life Sciences sector. Wiseek monitors IVRO SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.

Recent high-impact activity:

  • InVitro International Q3 Sales Plunge 24%, Net Income Drops 82%
$0.0515
52-week range · as of 2026-08-11 $0.025 – $0.16
Market cap
$1.14M
Volume
44.6K (1.1× avg)
3-mo avg 40.7K
Live data · 2026-08-11 15:46 UTC · Market open

show_chartPrice Chart

Loading chart...

feed IVRO - Latest Insights

IVRO
Aug 11, 2026, 9:00 AM EDT
Source: TMX Newsfile
Importance Score:
7
Price at Filing: $0.0679
Real-time Price: $0.0515 info
Change: -$0.0164 (-24%) info
Market Cap: $1.141M info